Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Picard MedicalPMI OCF Yield % is -190.92 as of Jul. 24, 2026. The stock has 4 warning signs investors should review. Among 850 Medical Devices & Instruments companies, Picard Medical ranks worse than 97.53% on this metric.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Picard Medical OCF Yield % Related Terms
Picard Medical OCF Yield % Historical Data
* Premium members only.
The historical data trend for Picard Medical's OCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Picard Medical's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Picard Medical OCF Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Picard Medical's OCF Yield % distribution charts can be found below:
* The bar in red indicates where Picard Medical's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Picard Medical (PMI) has a OCF Yield % of -190.92 as of Jul. 24, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Picard Medical and its competitors. According to the industry distribution chart, Picard Medical ranks #829 out of 850 companies in the Medical Devices & Instruments industry, placing it in the top 97.5%.
Is Picard Medical's OCF Yield % too high?
Picard Medical's current OCF Yield % is -190.92. Based on the distribution chart, Picard Medical ranks #829 out of 850 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers.
How does Picard Medical's OCF Yield % compare to ADGM and SINT?
According to the Medical Devices & Instruments industry distribution chart, Picard Medical ranks #829 out of 850 companies for OCF Yield %. This places Picard Medical in the lower half of its industry. The industry median OCF Yield % is 1.81. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Medical Devices & Instruments company?
The median OCF Yield % among Medical Devices & Instruments companies is 1.81, based on 850 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Picard Medical and its competitors. For the Medical Devices & Instruments industry, the median OCF Yield % is 1.81 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Picard Medical's current OCF Yield % is -190.92. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Picard Medical stock overvalued right now?
Picard Medical (PMI) has a current OCF Yield % of -190.92. The current OCF Yield % is -190.92. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Picard Medical (PMI), the current OCF Yield % is -190.92 as of Jul. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Picard Medical Inc operates through its wholly owned subsidiary, a medical technology company focused on developing, manufacturing, and commercializing the SynCardia TAH, an implantable total artificial heart system. The company is engaged in designing, manufacturing, producing, supplying, marketing, and selling medical device products, including the SynCardia TAH, which is designed to assume the full function of a failed human heart in patients suffering from advanced heart failure. The SynCardia TAH replaces both the left and right ventricles as well as all four heart valves.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PMI has been successfully added to your 
